The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2001-02-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0960-894X(00)00670-3PMID 11212100
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder

  2005cited by this paper
• A review of central 5-HT receptors and their function.

  1999cited by this paper
• Neutral acylation (protection) of the indole nitrogen: A simple synthesis of indole-1-carboxylates, indole-1-thiocarboxylates and indole-1-carboxamides

  1999cited by this paper
• Nicotinic agonists competitively antagonize serotonin at mouse 5-HT3 receptors expressed in Xenopus oocytes.

  1998cited by this paper
• Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding.

  1997cited by this paper
• Different effects of tropisetron and ondansetron in learning and memory paradigms.

  1997cited by this paper
• Progress in reducing nausea and emesis. Comparisons of ondansetron (zofran), granisetron (kytril), and tropisetron (navoban)

  1995cited by this paper
• Evolutionary history of the ligand-gated ion-channel superfamily of receptors.

  1995cited by this paper
• Molecular basis of muscarinic receptor function

  1993cited by this paper
• Molecular basis of muscarinic acetylcholine receptor function.

  1993cited by this paper

• Nicotinic acetylcholine receptors-targeting drug discovery.

  2026cites this paper
• Cocaine chemogenetics blunts drug-seeking by synthetic physiology

  2025cites this paper
• Activation of alpha-7 nicotinic acetylcholine receptor by tropisetron mitigates 3-nitropropionic acid-induced Huntington's disease in rats: Role of PI3K/Akt and JAK2/NF-κB signaling pathways.

  2024cites this paper
• Evaluation of the effect of intraoperative tropisetron on postoperative rebound pain after brachial plexus block: a randomized controlled trial

  2024cites this paper
• Advancements in Non-Dopaminergic Treatments for Schizophrenia: A Systematic Review of Pipeline Developments

  2024cites this paper
• Tropisetron, an Antiemetic Drug, Exerts an Anti‐Epileptic Effect Through the Activation of α7nAChRs in a Rat Model of Temporal Lobe Epilepsy

  2024cites this paper
• Postoperative pain management following laparoscopic cholecystectomy-non-opioid approaches: a review

  2024cites this paper
• Inflammation as a shared mechanism of chronic stress related disorders with potential novel therapeutic targets

  2024cites this paper
• Neuroimmune nexus in the pathophysiology and therapy of inflammatory disorders: role of α7 nicotinic acetylcholine receptors.

  2023cites this paper
• Synthesis, characterization, and in vitro anti-cholinesterase screening of novel indole amines

  2023cites this paper
• Therapeutic Targeting of a7 Nicotinic Acetylcholine Receptors

  2021influential citation
• Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors

  2021cites this paper
• Modulation of preeclampsia by the cholinergic anti-inflammatory pathway: therapeutic perspectives.

  2021cites this paper
• Tapping into 5-HT3 Receptors to Modify Metabolic and Immune Responses

  2021cites this paper
• Tropisetron ameliorates cyclophosphamide-induced hemorrhagic cystitis in rats.

  2020cites this paper
• Experimental and computational investigations of new indole derivatives: A combined spectroscopic, SC-XRD, DFT/TD-DFT and QTAIM analysis

  2020cites this paper
• Recent advances with 5-HT3 modulators for neuropsychiatric and gastrointestinal disorders.

  2020cites this paper
• Pharmacokinetic profile of the selective 5-HT3 receptor antagonist ondansetron in the rat: an original study and a mini-review of the behavioural pharmacological literature in the rat.

  2020cites this paper
• The Contribution of Serotonergic Receptors and Nitric Oxide Systems in the Analgesic Effect of Acetaminophen: An Overview of the Last Decade

  2020cites this paper
• Tropisetron enhances recognition memory in ovariectomized female rats

  2020cites this paper
• Targeting the α7 nicotinic acetylcholine receptor—A novel road towards the future treatment of skin diseases

  2020cites this paper
• Drug Discovery on Natural Products: From Ion Channels to nAChRs, from Nature to Libraries, from Analytics to Assays

  2019cites this paper
• Discovery of fused heterocyclic carboxamide derivatives as novel α7-nAChR agonists: Synthesis, preliminary SAR and biological evaluation.

  2019cites this paper
• 5-HT3 Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface

  2019cites this paper
• Cryo-EM structure of 5HT3A receptor in presence of granisetron

  2019cites this paper
• Tropisetron via α7 nicotinic acetylcholine receptor suppresses tumor necrosis factor‐α‐mediated cell responses of human keratinocytes

  2019cites this paper
• Molecular mechanism of setron-mediated inhibition of full-length 5-HT3A receptor

  2019cites this paper
• Ultrapotent chemogenetics for research and potential clinical applications

  2019cites this paper
• PharmGKB summary: Ondansetron and tropisetron pathways, pharmacokinetics and pharmacodynamics

  2019cites this paper
• Stimulation of nAchRα7 Receptor Inhibits TNF Synthesis and Secretion in Response to LPS Treatment of Mast Cells by Targeting ERK1/2 and TACE Activation

  2018cites this paper
• The Role of Human α7-Nicotinic Acetylcholine Receptors in Mediating Neuroprotective Action of Curcumin

  2018cites this paper
• Serotonin 3 receptor signaling regulates 5‐fluorouracil‐mediated apoptosis indirectly via TNF‐α production by enhancing serotonin release from enterochromaffin cells

  2018cites this paper
• Synthesis of Asthma Drug Zafirlukast (Accolate) Using Intramolecular Oxidative Coupling via sp3 C–H Bond Activation

  2018cites this paper
• Tropisetron enhances recognition memory in rats chronically treated with risperidone or quetiapine

  2017cites this paper
• The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials

  2017influential citation
• Pharmacology and Molecular Identity of Serotonin Receptor in Bivalve Mollusks

  2017cites this paper
• AS A NEUROPROTECTIVE AGENT AGAINST GLUTAMATE-INDUCED EXCITOTOXICITY : POTENTIAL MECHANISMS OF NEUROPROTECTION by

  2017influential citation
• Tropisetron sensitizes &agr;7 containing nicotinic receptors to low levels of acetylcholine in vitro and improves memory‐related task performance in young and aged animals

  2017influential citation
• The binding orientation of epibatidine at α7 nACh receptors

  2017cites this paper
• Protective effects of tropisetron on cerulein-induced acute pancreatitis in mice.

  2017cites this paper
• Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view.

  2017cites this paper
• BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia.

  2017cites this paper
• The binding orientations of structurally-related ligands can differ; A cautionary note

  2017cites this paper
• Development of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor Agonists.

  2017cites this paper
• Peripheral 5-HT3 Receptors Are Involved in the Antinociceptive Effect of Bunodosine 391

  2017cites this paper
• Development of spiroguanidine-derived α7 neuronal nicotinic receptor partial agonists.

  2017cites this paper
• The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors

  2016cites this paper
• Potential serotonergic agents for the treatment of schizophrenia

  2016cites this paper
• Postoperative Nausea and Vomiting: A Practical Guide

  2016cites this paper
• Update on New and Emerging Treatments for Schizophrenia.

  2016cites this paper
• Palonosetron-5-HT3 Receptor Interactions As Shown by a Binding Protein Cocrystal Structure.

  2016cites this paper
• The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia

  2016cites this paper
• Prevention of Glaucoma-Induced Retinal Ganglion Cell Loss Using Alpha7 nAChR Agonists

  2016cites this paper
• High resolution screening analytics for identification of natural bioactives

  2016cites this paper
• The α7 nicotinic acetylcholine receptor agonist tropisetron counteracts ultraviolet A‐mediated oxidative stress in human dermal fibroblasts

  2016cites this paper
• Synthesis of 4′-alkyl-8-azaspiro[bicyclo[3.2.1]octane-3,2′-morpholin]-5′-ones

  2016cites this paper
• Design and Synthesis of a New Series of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity Relationship.

  2016cites this paper
• Pharmacological profile of zacopride and new quaternarized fluorobenzamide analogues on mammalian α7 nicotinic acetylcholine receptor.

  2015cites this paper
• Tests for Anxiolytic Activity

  2015cites this paper
• Identification and in vitro pharmacological characterization of a novel and selective α7 nicotinic acetylcholine receptor agonist, Br-IQ17B

  2015cites this paper
• Hypoxia switches episodic breathing to singlet breathing in red-eared slider turtles (Trachemys scripta) via a tropisetron-sensitive mechanism.

  2015cites this paper
• Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker

  2015cites this paper
• Involvement of stimulation of α7 nicotinic acetylcholine receptors in the suppressive effect of tropisetron on dextran sulfate sodium-induced colitis in mice.

  2015cites this paper
• Development of Plate Reader and On-Line Microfluidic Screening to Identify Ligands of the 5-Hydroxytryptamine Binding Protein in Venoms

  2015cites this paper
• Nicotinic Acetylcholine Receptor Modulators

  2014cites this paper
• The multi-functional drug tropisetron binds APP and normalizes cognition in a murine Alzheimer's model.

  2014cites this paper
• Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: A potential

  2014cites this paper
• Tropisetron alleviate early post‐operative pain after gynecological laparoscopy in sevoflurane based general anaesthesia: A randomized, parallel‐group, factorial study

  2014cites this paper
• From Chemotherapy-Induced Emesis to Neuroprotection: Therapeutic Opportunities for 5-HT3 Receptor Antagonists

  2014cites this paper
• Human Brain Imaging of Acetylcholine Receptors

  2014cites this paper
• Tropisetron attenuates cisplatin-induced nephrotoxicity in mice.

  2014cites this paper
• Selective breeding for high alcohol preference increases the sensitivity of the posterior VTA to the reinforcing effects of nicotine

  2014cites this paper
• Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism.

  2014cites this paper
• Tropisetron as a neuroprotective agent against glutamate-induced excitotoxicity and mechanisms of action.

  2013cites this paper
• Quinuclidine compounds differently act as agonists of Kenyon cell nicotinic acetylcholine receptors and induced distinct effect on insect ganglionic depolarizations

  2013cites this paper
• Pharmacotherapy of cognitive deficits in schizophrenia

  2013cites this paper
• Neuronal nicotinic receptors as analgesic targets: it's a winding road.

  2013cites this paper
• Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model.

  2013cites this paper
• Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis.

  2013cites this paper
• Biomedical Importance of Indoles

  2013cites this paper
• Ondansetron reduces lasting vestibular deficits in a model of severe peripheral excitotoxic injury

  2013cites this paper
• Partial activation of α7 nicotinic acetylcholine receptors: insights from molecular dynamics simulations

  2013cites this paper
• Newer antipsychotics and upcoming molecules for schizophrenia

  2013cites this paper
• Tropisetron as a Neuroprotective Agent Against Glutamate-Induced Excitotoxicity: Potential Mechanisms of Neuroprotection

  2012influential citation
• Tropisetron and paracetamol association in post‐operative patients

  2012cites this paper
• Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia.

  2012cites this paper
• VUF10166, a Novel Compound with Differing Activities at 5-HT3A and 5-HT3AB Receptors

  2012cites this paper
• Impact of 5-HT₃ receptor antagonists on peripheral and central diseases.

  2012cites this paper
• The role of the &agr;7 nicotinic receptor in cognitive processing of persons with schizophrenia

  2012cites this paper
• A fluorinated quinuclidine benzamide named LMA 10203 acts as an agonist of insect nicotinic acetylcholine receptors.

  2012cites this paper
• Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor.

  2012cites this paper
• Liquid Chromatography-Mass Spectrometric Analysis of Tropane Alkaloids in Mammalian Samples: Techniques and Applications

  2012cites this paper
• INDOLE: THE MOLECULE OF DIVERSE BIOLOGICAL ACTIVITIES

  2012cites this paper
• Tropisetron, a 5-HT3 receptor antagonist, enhances object exploration in intact female rats

  2012cites this paper
• Discovery of (2S,3R)-N-[2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a selective α7 nicotinic acetylcholine receptor agonist, for the treatment of cognitive disorders.

  2012cites this paper
• α7 nicotinic acetylcholine receptor as a potential therapeutic target for schizophrenia.

  2011cites this paper
• Hippocampal Deletion of BDNF Gene Attenuates Gamma Oscillations in Area CA1 by Up-Regulating 5-HT3 Receptor

  2011cites this paper
• The stimulating effects of ethanol on ventral tegmental area dopamine neurons projecting to the ventral pallidum and medial prefrontal cortex in female Wistar rats: regional difference and involvement of serotonin-3 receptors

  2011cites this paper
• Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models

  2011cites this paper
• Discovery of Benzamide Analogues as a Novel Class of 5‐HT3 Receptor Agonists

  2011cites this paper